Emerging clinical evidence positions myeloid cell-derived PD-L1 as a potent immunosuppressive mediator in various malignancies10, 11, yet its radiation-inducible expression in ESCC-associated TAMs remains unexplored. The gene discussed is CD274; the disease is esophageal squamous cell carcinoma.